mercredi 2 décembre 2015

Onco Actu du 2 décembre 2015

1. Biologie

Cancer’s mutational sweet spot identified by Stanford researchers [Scope Blog]

CRISPR, The Revolutionary Gene-Editing Technique, Reveals Cancer’s Weaknesses [The Atlantic]

3. Prévention

Do potatoes reduce stomach cancer risk? [NHS Choices]

3.1 Tabac

BBC Panorama’s tobacco industry revelations are genuinely shocking [Cancer Research UK]

4.1 Dép., diag. & prono. - Prostate

A patient’s perspective on recent prostate cancer screening news [HealthNewsReview]

4.9 Dép., diag. & prono. - Sein

False Alarm Mammograms May Still Signal Higher Breast Cancer Risk [NPR]

5. Traitements

Complete surgical excision is the most effective treatment for breast implant-associated anaplastic large-cell lymphoma [MD Anderson Cancer Center]

5.12 Immunothérapies

Interview CEO of Cellectis: CAR-T is not the Cancer Cure-All [Labiotech]

5.2 Pharma

Puma preps its once-vaunted cancer drug for European submission [FierceBiotech]

5.4 Traitements - Economie

What difference does bargaining make to drug prices? In Norway, up to 58% off [FiercePharma]

Bristol-Myers puts a blockbuster $142K price on new cancer med Empliciti [FiercePharma]

5.5 ASCO

2016 Cancer Survivorship Symposium Press Program to Feature New Insights for Patient Care After Cancer Treatment [ASCO]

6.1 Observation

China to Have Over 800,000 Lung Cancer Patients a Year by 2020, State Media Says [TIME]